Scarlet lands $50M to speed up medical device approvals with AI

Scarlet has raised $50 Million in a Series B funding round. The company says the new capital will help it expand its AI platform for medical device certification, according to Pulse 2.0.

Why it matters

Medical device makers have to comply with strict regulations before they can sell products. Certification is slow and expensive. By using AI to speed up the process, Scarlet says it can lower costs and help new products reach the market faster. For health tech startups and established manufacturers, any reduction in time-to-approval can mean a significant advantage.

Scarlet's platform and the funding details

Scarlet's platform uses AI to automate parts of the medical device certification workflow. The $50 Million Series B round, reported by Pulse 2.0, is aimed at expanding this technology. The company has not disclosed which investors participated or what its total funding now stands at. According to Scarlet, the money will be used to develop new features and support more types of devices.

This funding comes as regulators in the US and Europe look for ways to handle a growing number of AI-driven health products. Companies like Microsoft have also called for clearer rules in AI regulation, as covered in our article here.

What this means if you run a business

If your company builds or sells medical devices, the certification process is a major bottleneck. An AI platform that can automate compliance tasks could let you bring products to market faster. That reduces the risk of missing windows in fast-moving health tech markets.

For leaders in other regulated industries, this is another sign that AI is moving into compliance and quality management. If you rely on manual or legacy systems for regulatory workflows, expect more vendors to pitch AI-driven alternatives. The $50 Million raised by Scarlet signals that investors see money to be made in automating red tape, not just new product features.